The University of Chicago Header Logo

Connection

Rima McLeod to Animals

This is a "connection" page, showing publications Rima McLeod has written about Animals.
Connection Strength

0.780
  1. Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites. Front Cell Infect Microbiol. 2020; 10:203.
    View in: PubMed
    Score: 0.046
  2. Seroprevalence of Toxoplasma gondii in domestic pets from metropolitan regions of Panama. Parasite. 2017; 24:9.
    View in: PubMed
    Score: 0.036
  3. Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii. JCI Insight. 2016 09 22; 1(15):e85955.
    View in: PubMed
    Score: 0.035
  4. New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Sci Rep. 2016 07 14; 6:29179.
    View in: PubMed
    Score: 0.035
  5. Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice. Vaccine. 2014 May 30; 32(26):3243-8.
    View in: PubMed
    Score: 0.030
  6. Spiroindolone that inhibits PfATPase4 is a potent, cidal inhibitor of Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob Agents Chemother. 2014; 58(3):1789-92.
    View in: PubMed
    Score: 0.029
  7. Salicylanilide inhibitors of Toxoplasma gondii. J Med Chem. 2012 Oct 11; 55(19):8375-91.
    View in: PubMed
    Score: 0.027
  8. Molecular target validation, antimicrobial delivery, and potential treatment of Toxoplasma gondii infections. Proc Natl Acad Sci U S A. 2012 Aug 28; 109(35):14182-7.
    View in: PubMed
    Score: 0.026
  9. Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway. Antimicrob Agents Chemother. 2012 May; 56(5):2666-82.
    View in: PubMed
    Score: 0.026
  10. Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality. Parasitology. 2012 Jan; 139(1):1-13.
    View in: PubMed
    Score: 0.025
  11. Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-? and reduces parasite burden in HLA-B*0702 mice. Hum Immunol. 2012 Jan; 73(1):1-10.
    View in: PubMed
    Score: 0.025
  12. T. gondii RP promoters & knockdown reveal molecular pathways associated with proliferation and cell-cycle arrest. PLoS One. 2010 Nov 22; 5(11):e14057.
    View in: PubMed
    Score: 0.023
  13. Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine. 2011 Jan 17; 29(4):754-62.
    View in: PubMed
    Score: 0.023
  14. Identification and development of novel inhibitors of Toxoplasma gondii enoyl reductase. J Med Chem. 2010 Sep 09; 53(17):6287-300.
    View in: PubMed
    Score: 0.023
  15. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine. 2010 May 21; 28(23):3977-89.
    View in: PubMed
    Score: 0.022
  16. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz. 2009 Mar; 104(2):320-44.
    View in: PubMed
    Score: 0.021
  17. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J Neuroinflammation. 2008 Oct 23; 5:48.
    View in: PubMed
    Score: 0.020
  18. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo. PLoS Negl Trop Dis. 2008 Mar 05; 2(3):e190.
    View in: PubMed
    Score: 0.019
  19. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. Pediatr Infect Dis J. 2006 Mar; 25(3):270-2.
    View in: PubMed
    Score: 0.017
  20. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo. Antimicrob Agents Chemother. 2005 Aug; 49(8):3463-7.
    View in: PubMed
    Score: 0.016
  21. Evidence for mitochondrial-derived alternative oxidase in the apicomplexan parasite Cryptosporidium parvum: a potential anti-microbial agent target. Int J Parasitol. 2004 Mar 09; 34(3):297-308.
    View in: PubMed
    Score: 0.015
  22. Delivery of antimicrobials into parasites. Proc Natl Acad Sci U S A. 2003 Nov 25; 100(24):14281-6.
    View in: PubMed
    Score: 0.014
  23. In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain. J Immunol. 2002 Jul 15; 169(2):966-73.
    View in: PubMed
    Score: 0.013
  24. The shikimate pathway and its branches in apicomplexan parasites. J Infect Dis. 2002 Feb 15; 185 Suppl 1:S25-36.
    View in: PubMed
    Score: 0.013
  25. Genetic analysis of influences on survival following Toxoplasma gondii infection. Int J Parasitol. 2002 Feb; 32(2):179-85.
    View in: PubMed
    Score: 0.013
  26. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. Int J Parasitol. 2001 Feb; 31(2):109-13.
    View in: PubMed
    Score: 0.012
  27. Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice. Sci Rep. 2020 10 12; 10(1):16984.
    View in: PubMed
    Score: 0.012
  28. Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii. Int J Parasitol. 2000 Feb; 30(2):149-55.
    View in: PubMed
    Score: 0.011
  29. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol. 2000 Jan; 22(1):1-5.
    View in: PubMed
    Score: 0.011
  30. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int J Parasitol. 1999 Sep; 29(9):1351-8.
    View in: PubMed
    Score: 0.011
  31. The One Health Approach to Toxoplasmosis: Epidemiology, Control, and Prevention Strategies. Ecohealth. 2019 06; 16(2):378-390.
    View in: PubMed
    Score: 0.010
  32. Prevalence and genetic characterization of Toxoplasma gondii in free-range chickens from grocery stores and farms in Maryland, Ohio and Massachusetts, USA. Parasitol Res. 2017 May; 116(5):1591-1595.
    View in: PubMed
    Score: 0.009
  33. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis. 1996 Nov; 23(5):1055-60.
    View in: PubMed
    Score: 0.009
  34. The zebrafish, Danio rerio, as a model for Toxoplasma gondii: an initial description of infection in fish. J Fish Dis. 2015 Jul; 38(7):675-9.
    View in: PubMed
    Score: 0.008
  35. ?d Intraepithelial Lymphocyte Migration Limits Transepithelial Pathogen Invasion and Systemic Disease in Mice. Gastroenterology. 2015 Jun; 148(7):1417-26.
    View in: PubMed
    Score: 0.008
  36. Effects of human class I transgenes on Toxoplasma gondii cyst formation. J Immunol. 1994 May 01; 152(9):4537-41.
    View in: PubMed
    Score: 0.007
  37. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii. ChemMedChem. 2013 Jul; 8(7):1138-60.
    View in: PubMed
    Score: 0.007
  38. Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii. Infect Immun. 2012 Dec; 80(12):4298-308.
    View in: PubMed
    Score: 0.007
  39. Identification of a sporozoite-specific antigen from Toxoplasma gondii. J Parasitol. 2011 Apr; 97(2):328-37.
    View in: PubMed
    Score: 0.006
  40. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J Immunol. 1990 Nov 15; 145(10):3438-41.
    View in: PubMed
    Score: 0.006
  41. Immunogenetics of Toxoplasma gondii informs vaccine design. Trends Parasitol. 2010 Nov; 26(11):550-5.
    View in: PubMed
    Score: 0.006
  42. P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol. 2010 Jun 15; 184(12):7040-6.
    View in: PubMed
    Score: 0.006
  43. Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life. Am J Ophthalmol. 2008 Sep; 146(3):375-384.
    View in: PubMed
    Score: 0.005
  44. Subcellular localization and dynamics of a digalactolipid-like epitope in Toxoplasma gondii. J Lipid Res. 2008 Apr; 49(4):746-62.
    View in: PubMed
    Score: 0.005
  45. Lipidomic analysis of Toxoplasma gondii reveals unusual polar lipids. Biochemistry. 2007 Dec 04; 46(48):13882-90.
    View in: PubMed
    Score: 0.005
  46. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents. Acta Crystallogr D Biol Crystallogr. 2007 Mar; 63(Pt 3):328-38.
    View in: PubMed
    Score: 0.005
  47. Evolutionary origins of the eukaryotic shikimate pathway: gene fusions, horizontal gene transfer, and endosymbiotic replacements. Eukaryot Cell. 2006 Sep; 5(9):1517-31.
    View in: PubMed
    Score: 0.004
  48. Expression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2006 Jun 01; 62(Pt 6):604-6.
    View in: PubMed
    Score: 0.004
  49. The unusual mitochondrial compartment of Cryptosporidium parvum. Trends Parasitol. 2005 Feb; 21(2):68-74.
    View in: PubMed
    Score: 0.004
  50. Expression, purification and crystallization of the Plasmodium falciparum enoyl reductase. Acta Crystallogr D Biol Crystallogr. 2003 Jul; 59(Pt 7):1246-8.
    View in: PubMed
    Score: 0.004
  51. Toxoplasma gondii tachyzoite-bradyzoite interconversion. Trends Parasitol. 2002 May; 18(5):198-201.
    View in: PubMed
    Score: 0.003
  52. Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase. Proc Natl Acad Sci U S A. 1999 Nov 09; 96(23):13387-92.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.